Completed

Phase 2
Age: 21Years - 55Years
All Genders
ID00460239

Evaluation of Opioid Antagonist Activity in Humans

Led by Johns Hopkins University · Updated on 2017-03-03

12

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a residential study that looks at the effects of buprenorphine in persons who abuse but are not dependent on opioids. Animal studies show that very high doses of buprenorphine produce less effects than mid-range doses. This suggests that buprenorphine can be a very safe medication. However, no studies in humans have tested higher doses in a similar way. The goal of this study is to show the effects of single doses of buprenorphine, across a range of doses, in persons who are not physically dependent on opioids (but do abuse opioids).

CONDITIONS

Official Title

Buprenorphine's Dose Response Curve

Who Can Participate

Age: 21Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

1. current opioid abuse but not physically dependent on opioids

Not Eligible

You will not qualify if you...

  1. evidence of significant medical (e.g., insulin dependent diabetes) or psychiatric (e.g., schizophrenia) illness
  2. anemia defined as a hematocrit less than 30%
  3. females are required to provide a negative pregnancy test prior to study participation
  4. baseline electrocardiogram (ECG) showing prolongation of the corrected QT interval (QTc)
  5. current significant alcohol or sedative/hypnotic drug use
  6. Forced expiratory volume at one second (FEV1) of less than 50% at the time of screening
  7. applicants seeking treatment for their substance abuse will not be admitted to the study, and should be provided information about treatment services available

Trial Site Locations

Total: 1 location

1

Johns Hopkins University (BPRU) Bayview Campus

Baltimore, Maryland, United States, 21224

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

8

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of Opioid Antagonist Activity in Humans | DecenTrialz